1 min read





MÖLNLYCKE HEALTH CARE CEO Pierre Guyot cuts the ribbon during Tuesday’s formal “inauguration” ceremony at the Swedish company’s Brunswick Landing manufacturing plant. Although mostly operational, the $15 million, 72,000-square-foot facility still awaits installation and calibration of almost $35 million worth of machinery that, at full production, will churn out one million hightech bandages per week. “Getting to this stage has been challenging and rewarding,” said Mark Dignum, Mölnlycke’s Brunswick site director, “but the building is the easy bit. Integrating and coordinating the systems during the next several months is the next challenge.” Pictured with Guyot are George Gervais, at left, commissioner of the Maine Department of Economic and Community Development, and at right are Phil Cooper, Mölnlycke’s Global President of Wound Care and Jim Wetrich, president of North and Latin Americas divisions.
MÖLNLYCKE HEALTH CARE CEO Pierre Guyot cuts the ribbon during Tuesday’s formal “inauguration” ceremony at the Swedish company’s Brunswick Landing manufacturing plant. Although mostly operational, the $15 million, 72,000-square-foot facility still awaits installation and calibration of almost $35 million worth of machinery that, at full production, will churn out one million hightech bandages per week. “Getting to this stage has been challenging and rewarding,” said Mark Dignum, Mölnlycke’s Brunswick site director, “but the building is the easy bit. Integrating and coordinating the systems during the next several months is the next challenge.” Pictured with Guyot are George Gervais, at left, commissioner of the Maine Department of Economic and Community Development, and at right are Phil Cooper, Mölnlycke’s Global President of Wound Care and Jim Wetrich, president of North and Latin Americas divisions.

Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.